The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations
Open Access
- 1 December 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 73 (4) , 655-672
Abstract
Although the use of cryoprotectant dimethyl sulfoxide (DMSO) is the gold standard in cryopreservation of hematopoietic stem cells, it is well known that it has a negative effect on cell viability. The aim of this prospective study was to examine how the length of post-thaw exposure to DMSO affects the cell viability and stability of peripheral blood stem cell (PBSC) samples. Additionally, the effects of donor type and pre-cryopreservation storage time on post-thaw viability during the stability study were evaluated. In 30 autologous and 30 allogeneic PBSC samples viable CD34+, CD14+, CD19+, CD16+/56+, and CD3+ cells were determined immediately after thawing, and one-and three-hours post-thaw. Analysis of the absolute count of viable cells in thawed samples showed a significant difference between all measurement points for CD34+ ( p < 0.001), CD14+ ( p < 0.001), and CD19+ cells ( p < 0.001). No significant differences were observed for post-thaw stability of allogeneic samples analysed between products stored before cryopreservation ≥ 24 hours (N = 20), and those stored < 24 hours (N = 10), except for viable CD3+/CD4+ cells after three hours post-thaw ( p = 0.028). In conclusion, DMSO had different effects on leukocyte subpopulations in cryopre-served PBSC samples. The type of donors and the length of storage before cryopreservation did not affect the post-thaw stability of cryopreserved PBSC samples.Keywords
This publication has 17 references indexed in Scilit:
- Processing, Cryopreserving and Controlling the Quality of HSCs2018
- Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis productsCytotherapy, 2016
- Relevance of flow cytometric enumeration of post‐thaw leucocytes: influence of temperature during cell staining on viable cell recoveryVox Sanguinis, 2016
- Blood graft cellular composition and posttransplant recovery in non‐Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparisonTransfusion, 2015
- Assessing the toxic effects of DMSO on cord blood to determine exposure time limits and the optimum concentration for cryopreservationVox Sanguinis, 2015
- Optimal length of time of cryopreserved umbilical cord blood infusion after thawingHematology, 2013
- Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantationTransfusion, 2013
- Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusionBone Marrow Transplantation, 2013
- Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantationBone Marrow Transplantation, 2003
- Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter studyCytotherapy, 2003